American Century Companies Inc. Has $2.99 Million Holdings in Teladoc Health, Inc. $TDOC

Key Points

• American Century Companies Inc. significantly increased its stake in Teladoc Health by 78.8% during the 1st quarter, now holding 375,050 shares valued at approximately $2.98 million.
• Several institutional investors have also raised their stakes in Teladoc, with National Bank of Canada FI increasing its position by 79.4% in the same quarter.
• Wall Street analysts have mixed ratings on Teladoc, with a consensus target price of $9.80 and most ratings reflecting a "Hold" stance.

American Century Companies Inc. raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 78.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 375,050 shares of the health services provider's stock after purchasing an additional 165,332 shares during the period. American Century Companies Inc. owned about 0.21% of Teladoc Health worth $2,985,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. Golden State Wealth Management LLC boosted its position in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares during the period. National Bank of Canada FI boosted its holdings in Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,581 shares during the last quarter. Brucke Financial Inc. purchased a new position in Teladoc Health in the fourth quarter valued at about $92,000. Westside Investment Management Inc. increased its position in shares of Teladoc Health by 16.8% during the first quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock worth $86,000 after acquiring an additional 1,550 shares during the last quarter. Finally, AE Wealth Management LLC bought a new stake in Teladoc Health in the first quarter valued at about $93,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Evercore ISI increased their target price on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Mizuho began coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price for the company. Wells Fargo & Company lowered their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Truist Financial dropped their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Finally, Bank of America lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Six analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $9.80.

Teladoc Health Price Performance

Shares of TDOC stock traded up $0.16 on Friday, reaching $7.79. 1,618,709 shares of the company were exchanged, compared to its average volume of 6,810,708. The business has a 50-day moving average price of $7.79 and a 200 day moving average price of $7.89. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -6.55 and a beta of 1.84.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business's quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Equities research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.